Fred Appelbaum

Scientific Advisor at Jasper Therapeutics

Dr. Appelbaum studies the biology and treatment of leukemias, lymphomas and other blood cancers and sees patients with these disorders. He has made numerous landmark contributions to his field. Notably, he helped develop the renowned program in blood stem cell transplantation at the Fred Hutchinson Cancer Research Center, where he participated in its pioneering work to develop targeted antibody-based cancer therapies. Today, Dr. Appelbaum leads the Adult Leukemia Research Center and the Hematologic Malignancy Program of the Fred Hutchinson/University of Washington Cancer Consortium. These efforts are aimed at enhancing the understanding of these diseases and improving treatments such as blood stem cell transplantation. As Fred Hutch Deputy Director, Dr. Appelbaum leads the implementation of key scientific strategies and partnerships. He also helps to ensure that Fred Hutch advances are shared with the wider community.


  • Scientific Advisor

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.